Patient Organization Collaboration Promotion Committee
We will actively exchange opinions with patient groups to promote mutual understanding, consider initiatives from the patients' perspective, and work together better with patient groups. In addition, we will make efforts to disseminate the "Transparency Guidelines for Relationships between Corporate Activities and Patient Organizations".
Announcements and Updates
-
Patient Organization Collaboration Promotion Committee
Reference: "Association for Creating a Society Where Everyone Has Easy Access to Clinical Trials" has been updated.
-
Patient Organization Collaboration Promotion Committee
The article by Dr. Misawa, Chairperson of the Patient Groups Collaboration Promotion Committee, was published in Nikkan Yakugyo.
-
Patient Organization Collaboration Promotion Committee
Reference: "Association for Creating a Society Where Everyone Has Easy Access to Clinical Trials" has been updated.
-
Patient Organization Collaboration Promotion Committee
The "Transparency Guideline for the Relationship between Corporate Activities and Patient Groups" has been updated.
-
Patient Organization Collaboration Promotion Committee
Reference] Association for Creating a Society Where Clinical Trials are Accessible to All" has been updated.
Content of the Committee for Promotion of Collaboration with Patient Organizations
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Guidelines for Collaboration with Patient Organizations
Guidelines for Collaboration with Patient Groups" is available.
-
Transparency Guidelines for Relationships between Corporate Activities and Patient Groups
Transparency Guidelines and public information of member companies are posted.
-
Holding seminars for patient groups
Patient Organization Seminars are held twice a year to provide useful information to patient organizations and as a forum for exchanges to deepen mutual understanding among organizations, as well as between pharmaceutical association member companies and patient organizations. (Venue: Tokyo and Osaka)
-
Patient Organization Advisory Board
The Pharmaceutical Industry Association of Japan (PIAJ) is a forum where the pharmaceutical industry and patient groups can learn together on timely topics, build transparent and appropriate relationships, and exchange opinions on cooperation and measures to solve common problems.
-
Patient Organization Survey Report
In order to learn about the activities of patient groups in Japan and the challenges they face, we are conducting a "Survey of Patient Groups' Awareness and Activities".
-
(Reference) Association for Creating a Society in which Clinical Trials are Accessible to All
Information about the "Association for Creating a Society in which Clinical Trials are Accessible to All", for which the Patient Organization Collaboration Promotion Committee serves as the secretariat.
-
Case Studies on PPI (Patient and Public Participation)
Examples of collaboration between pharmaceutical companies and patient groups are posted.
-
Announcements from the Patient Organization Collaboration Promotion Committee
Various announcements from the Patient Organization Collaboration Promotion Committee are posted.